Eletriptan for acute migraine

Migraine is a significant health problem affecting about 18% of women and 6% of men, and many drugs are available for its treatment. Eletriptan is a new drug which will soon be available by prescription. Data from trials undertaken by the manufacturer and analysed independently by the reviewers show...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2001-07, Vol.2001 (3)
Main Authors: Smith, Lesley A, Oldman, Anna, McQuay, Henry J, Moore, R Andrew, Derry, Sheena
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Migraine is a significant health problem affecting about 18% of women and 6% of men, and many drugs are available for its treatment. Eletriptan is a new drug which will soon be available by prescription. Data from trials undertaken by the manufacturer and analysed independently by the reviewers showed that treatment of an acute migraine attack with eletriptan 20 mg, 40 mg or 80 mg provided significant pain relief from 0.5 to 24 hours. The incidence of adverse effects was dose‐related, with patients taking eletriptan 80 mg reporting more adverse effects.
ISSN:1469-493X
DOI:10.1002/14651858.CD003224.pub2